130 related articles for article (PubMed ID: 19422351)
1. Acute cytomegalovirus cholecystitis following renal transplantation.
Drage M; Reid A; Callaghan CJ; Baber Y; Freeman S; Huguet E; Watson CJ
Am J Transplant; 2009 May; 9(5):1249-52. PubMed ID: 19422351
[TBL] [Abstract][Full Text] [Related]
2. Incidence and risk factors associated with cytomegalovirus infection after the treatment of acute rejection during the first year in kidney transplant recipients receiving preemptive therapy.
Felipe C; Ferreira AN; de Paula M; Viana L; Cristelli M; Medina Pestana J; Tedesco-Silva H
Transpl Infect Dis; 2019 Dec; 21(6):e13106. PubMed ID: 31081566
[TBL] [Abstract][Full Text] [Related]
3. Cytomegalovirus infection of the major duodenal papilla in a renal allograft recipient with severe biliary obstruction and acalculous cholecystitis.
Riediger C; Beimler J; Weitz J; Zeier M; Sauer P
Transpl Infect Dis; 2013 Aug; 15(4):E129-33. PubMed ID: 23790000
[TBL] [Abstract][Full Text] [Related]
4. Ureteritis and cholecystitis: two unusual manifestations of cytomegalovirus disease in renal transplant recipients.
Moudgil A; Germain BM; Nast CC; Toyoda M; Strauss FG; Jordan SC
Transplantation; 1997 Oct; 64(7):1071-3. PubMed ID: 9381531
[TBL] [Abstract][Full Text] [Related]
5. Reassessing the impact of cytomegalovirus infection in kidney and kidney-pancreas transplantation.
Becker BN; Becker YT; Leverson GE; Simmons WD; Sollinger HW; Pirsch JD
Am J Kidney Dis; 2002 May; 39(5):1088-95. PubMed ID: 11979354
[TBL] [Abstract][Full Text] [Related]
6. Perforation of the gallbladder in a patient with acute cytomegalovirus cholecystitis shortly following renal transplantation.
Imaoka Y; Ohira M; Ishiyama K; Ide K; Kobayashi T; Tahara H; Ohdan H
Transpl Infect Dis; 2017 Oct; 19(5):. PubMed ID: 28605108
[TBL] [Abstract][Full Text] [Related]
7. Cytomegalovirus-related disease and risk of acute rejection in renal transplant recipients: a cohort study with case-control analyses.
Toupance O; Bouedjoro-Camus MC; Carquin J; Novella JL; Lavaud S; Wynckel A; Jolly D; Chanard J
Transpl Int; 2000; 13(6):413-9. PubMed ID: 11140239
[TBL] [Abstract][Full Text] [Related]
8. The risk of cytomegalovirus infection after treatment of acute rejection in renal transplant recipients.
Jorgenson MR; Descourouez JL; Lyu B; Astor BC; Garg N; Smith JA; Mandelbrot DA
Clin Transplant; 2019 Aug; 33(8):e13636. PubMed ID: 31194887
[TBL] [Abstract][Full Text] [Related]
9. High risk of cytomegalovirus infection following solid organ transplantation despite prophylactic therapy.
Harvala H; Stewart C; Muller K; Burns S; Marson L; MacGilchrist A; Johannessen I
J Med Virol; 2013 May; 85(5):893-8. PubMed ID: 23508914
[TBL] [Abstract][Full Text] [Related]
10. Cytomegalovirus prophylaxis in seropositive renal transplant recipients receiving thymoglobulin induction therapy: Outcome and risk factors for late CMV disease.
Reusing JO; Feitosa EB; Agena F; Pierrotti LC; Azevedo LSF; Kotton CN; David-Neto E
Transpl Infect Dis; 2018 Oct; 20(5):e12929. PubMed ID: 29809309
[TBL] [Abstract][Full Text] [Related]
11. Cytomegalovirus infection after acute rejection therapy in seropositive kidney transplant recipients.
Lee YM; Kim YH; Han DJ; Park SK; Park JS; Sung H; Hong HL; Kim T; Kim SH; Choi SH; Kim YS; Woo JH; Lee SO
Transpl Infect Dis; 2014 Jun; 16(3):397-402. PubMed ID: 24810355
[TBL] [Abstract][Full Text] [Related]
12. Differentiation of cytomegalovirus infection from acute rejection using renal allograft fine needle aspirates.
Nast CC; Wilkinson A; Rosenthal JT; Barba L; Bretan PN; Beaumont P; Danovitch GM
J Am Soc Nephrol; 1991 May; 1(11):1204-11. PubMed ID: 1657240
[TBL] [Abstract][Full Text] [Related]
13. Delayed graft function and rejection are risk factors for cytomegalovirus breakthrough infection in kidney transplant recipients.
Kleinherenbrink W; Baas M; Nakhsbandi G; Hesselink DA; Roodnat JI; de Winter BC; Hilbrands L; van Gelder T
Pharmacol Res; 2021 May; 167():105565. PubMed ID: 33744428
[TBL] [Abstract][Full Text] [Related]
14. Sero-molecular evaluation of human cytomegalovirus disease in renal transplant rejection.
Kishore J; Mukhopadhyay C; Savitri ; Ayyagari A; Sharma RK
Nepal Med Coll J; 2004 Dec; 6(2):83-7. PubMed ID: 16295735
[TBL] [Abstract][Full Text] [Related]
15. Is antibody-mediated rejection in kidney transplant recipients a risk factor for developing cytomegalovirus or BK virus infection? Results from a case-control study.
Los-Arcos I; Len O; Perello M; Torres IB; Codina G; Esperalba J; Sellarés J; Moreso F; Seron D; Gavaldà J
J Clin Virol; 2019 Jan; 110():45-50. PubMed ID: 30537648
[TBL] [Abstract][Full Text] [Related]
16. Cholecystectomy for Acute Cholecystitis After Renal Transplantation.
Varga M; Kudla M; Vargova L; Fronek J
Transplant Proc; 2016; 48(6):2072-5. PubMed ID: 27569946
[TBL] [Abstract][Full Text] [Related]
17. Use of mTOR inhibitor as prophylaxis for cytomegalovirus disease after kidney transplantation: A natural experiment.
Cristelli MP; Felipe CR; Prizmic PSS; de Azevedo VFD; Viana LA; Tavares MG; Wagner de Castro Lima Santos D; de Paula MI; Medina-Pestana JO; Tedesco-Silva Junior H
Clin Transplant; 2019 Oct; 33(10):e13689. PubMed ID: 31400155
[TBL] [Abstract][Full Text] [Related]
18. Cytomegalovirus infection post-pancreas-kidney transplantation--results of antiviral prophylaxis in high-risk patients.
Fallatah SM; Marquez MA; Bazerbachi F; Schiff JR; Cattral MS; McGilvray ID; Norgate A; Selzner M; Rotstein C; Husain S
Clin Transplant; 2013; 27(4):503-9. PubMed ID: 23731387
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology of pretransplant EBV and CMV serostatus in relation to posttransplant non-Hodgkin lymphoma.
Opelz G; Daniel V; Naujokat C; Döhler B
Transplantation; 2009 Oct; 88(8):962-7. PubMed ID: 19855238
[TBL] [Abstract][Full Text] [Related]
20. Cytomegalovirus infection after organ transplantation: an update with special emphasis on renal transplantation.
van Son WJ; The TH
Transpl Int; 1989 Oct; 2(3):147-64. PubMed ID: 2553045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
